Prognostic markers of lymphoblastic lymphoma
- Authors: Volchkov E.V.1, Olshanskaya Y.V.1, Myakova N.V.1
-
Affiliations:
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
- Issue: Vol 19, No 4 (2020)
- Pages: 198-204
- Section: LITERATURE REVIEW
- Submitted: 22.12.2020
- Accepted: 22.12.2020
- Published: 08.07.2025
- URL: https://hemoncim.com/jour/article/view/436
- DOI: https://doi.org/10.24287/1726-1708-2020-19-4-198-204
- ID: 436
Cite item
Full Text
Abstract
Lymphoblastic lymphoma (LBL) is the second most common non-Hodgkin's lymphoma in childhood. According to modern concepts LBL and acute lymphoblastic leukemia (ALL) are considered as manifestations of the same disease given the similar morphological substrate of the tumor – T and B lymphoblasts. The standard for the treatment of LBL is currently ALL-like riskadapted treatment protocols that allow achieving overall and event-free survival rates of 80–90%. The division into risk groups is based on the stage of the disease and the response to induction therapy. However, the problem of relapse/refractory course of the disease remains a serious problem due to the lack of sufficiently effective therapeutic options. Currently, there is a sufficient amount of clinical data that reliably shows that a number of molecular biological factors can be used to create a new system of into risk groups stratification of patients with LBL. This review focuses on the analysis of various factors that may be responsible for the prognosis of LBL in children.
About the authors
E. V. Volchkov
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
Author for correspondence.
Email: volchcov.egor@yandex.ru
ORCID iD: 0000-0002-2574-1636
Egor V. Volchcov, a research technician at the Lymphoma Research Department
1 Samory Mashela St., Moscow 117997
Russian FederationYu. V. Olshanskaya
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
ORCID iD: 0000-0002-2352-7716
Moscow Russian Federation
N. V. Myakova
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
ORCID iD: 0000-0002-4779-1896
Moscow Russian Federation
References
Supplementary files
